Active
Mainboard

Sudeep Pharma Ltd

Sudeep Pharma Ltd IPO opened on 21 Nov 2025 and closed on 25 Nov 2025, with a price band of ₹563–₹593 per share. The IPO had a lot size of 25 shares, requiring a minimum investment of ₹14,825 per lot at the upper price band. The issue size was ₹895 crore, and the shares get listed on 28 Nov 2025.

Sudeep Pharma Ltd IPO Details

Listing Date

28 Nov 2025

Bid Price

₹563 - ₹593

Lot Size

25 Shares

Minimum Investment

₹14,825 / Lot

Issue Size

₹895 Cr

Key Dates to Track

    Here are the important dates you need to know in order to participate in this IPO

tick

Offer Start Date

21st Nov

tick

Offer End Date

25th Nov

tick

Allotment Date

26th Nov

tick

Refund Initiation

27th Nov

tick

Demat Transfer

27th Nov

tick

Listing Date

28th Nov

About Sudeep Pharma Ltd IPO

Sudeep Pharma Ltd, founded in 1989, is seeking to raise about ₹95 crore through a fresh issue in its IPO, alongside a promoter-led offer-for-sale of roughly 1,00,76,492 shares. The company intends to deploy approximately ₹75.81 crore of the fresh proceeds toward capital expenditure, particularly for machinery procurement at its Nandesari facility. At the same time, the rest is earmarked for general corporate purposes.
 

On the business side, Sudeep Pharma is a manufacturer of excipients and speciality mineral-based ingredients for the pharmaceutical, food, and nutrition sectors. It operates three manufacturing facilities in Vadodara, Gujarat, with a combined capacity of 65,579 metric tonnes as of 31 December 2024. The company has a global presence, supplying customers in over 100 countries. Its financials for the nine months ended 31 December 2024 show a revenue of ₹344.45 crore and a profit after tax of ₹94.54 crore.

Sudeep Pharma Ltd Shareholding Pattern

  Pre-Issue Post-Issue
Promoter Group 89.37% 76.15%
Public Group 10.63% 23.85%

Sudeep Pharma Ltd IPO Reservation

QIB Shares Offered 30,18,550 (20%)
NII (HNI) Shares Offered 22,63,913 (15%)
Retail Shares Offered 52,82,462 (35%)
Anchor Investor Shares Offered 45,27,825 (30%)
Total Shares Offered 1,50,92,750
Total Shares With Anchor Investor 1,50,92,750

Sudeep Pharma Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 25 ₹14,825
Retail (Max) 13 325 ₹1,92,725
S HNI (Min) 14 350 ₹2,07,550
S HNI (Max) 67 1,675 ₹9,93,275
B HNI (MIN) 68 1,700 ₹10,08,100

Sudeep Pharma Ltd IPO Anchor Portion Size

Bid Date November 20, 2025
Shares Offered 45,27,823
Anchor Investment Details 268.4999039

Sudeep Pharma Ltd IPO registrar

MUFG Intime India Pvt Ltd
Phone Number +91 81 0811 4949
Email Id sudeeppharma.ipo@in.mpms.mufg.com
Website https://in.mpms.mufg.com

Sudeep Pharma Ltd IPO Lead Manager

1. ICICI Securities Limited

2. IIFL Capital Services Limited

Sudeep Pharma Ltd Financial Information

March 31, 2025 March 31, 2024 March 31, 2022
Net Worth ₹493.09 Cr ₹356 Cr ₹163.34 Cr
Reserves and Surplus ₹481.11 Cr ₹354.59 Cr ₹161.93 Cr
Total Borrowing ₹135.25 Cr ₹75.03 Cr ₹83.69 Cr

Sudeep Pharma Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid Subscription (Times)
Qualified Institutional Buyers (QIBs) 30,18,550 64,31,88,450 213.08
Non Institutional Investors (NIIs) 22,63,913 26,42,40,450 116.72
Retail Individual Investors (RIIs) 52,82,463 8,26,71,250 15.65
Total 1,05,64,926 99,01,00,150 93.72

Strength of Sudeep Pharma Ltd

  • Market leadership with a diversified product portfolio in a high barrier industry.
  • Distinguished global customer base with long-standing relationships with key customers.
  • Well-equipped and regulatory compliant Manufacturing Facilities.
  • Strong research and development capabilities.
  • Experienced Promoters and senior management team.

Risks Involved

  • The company generates a significant portion of its revenues from a limited number of customers and the loss of such customers or a decline in demand from such customers could adversely affect the company's business, results of operations, financial condition, and cash flows.
  • The company generated 66.43%, 65.84%, 67.64% and 77.01% of its revenue from operations from the company's pharmaceutical, food and nutrition segment, in the three months ended June 30, 2025 and Fiscals 2025, 2024 and 2023, respectively. Any adverse developments affecting this segment may adversely affect its business, results of operations, financial condition, and cash flows.
  • The company's Manufacturing Facilities are subject to periodic inspections and audits by regulatory authorities and customers and any manufacturing or quality control problems may subject us to regulatory action, damage its eputation and have an adverse effect on its business and results of operations.
  • Three of the company's four Manufacturing Facilities and one of its two R&D facilities are concentrated in a single region and any adverse developments affecting this region could have an adverse effect on the company's business, results of operations, financial condition and cash flows.
  • Any disruption, slowdown or shutdown in the company's manufacturing or R&D operations could adversely affect its business, results of operations, financial condition and cash flows.
  • The company generates a substantial portion of its revenue from operations from the company's export sales (58.68%, 59.27%, 64.43% and 68.45% of its revenue from operations for the three months ended June 30, 2025 and Fiscals 2025, 2024 and 2023, respectively) and any adverse developments in such regions, including the imposition of tariffs or other anti-sourcing legislation, could adversely affect the company's business, results of operations, financial condition and cash flows.
  • If the company is unable to introduce new products in a timely manner or if the products the company commercialize do not perform as expected, the company's business, results of operations, financial condition and cash flows may be adversely affected.
  • The company has recently undertaken the NSS Acquisition and may undertake similar acquisitions, investments, joint ventures or other strategic alliances in the future, which if unsuccessful, may adversely affect its business, results of operations and financial condition.
  • Any delay, interruption or reduction in the supply of raw materials and equipment to manufacture the company's products may adversely affect its business, results of operations, financial condition and cash flows.
  • The company's past performance may not be indicative of its future growth. The company may not be successful in implementing and managing its expansion and growth strategy effectively. Further, the company intend to diversify into different businesses beyond the pharmaceutical sphere, and failures to successfully implement such business ventures can negatively impact the company's results of operations and financial condition.
stock

Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Industry Outlook of Sudeep Pharma IPO

  • The Indian pharmaceutical-ingredients space is supported by growing demand for excipients and specialty minerals, especially calcium-based products.

  • Sudeep Pharma operates in both the pharmaceutical and nutrition verticals, tapping into cross-industry tailwinds.

  • The company has an established global footprint, supplying to over 100 countries, which aligns with rising export trends in pharma ingredients.

  • Its production capacity is relatively large (65,579 metric tonnes across three plants), positioning it to scale with demand.

  • Acquisition of a European premix business (Nutrition Supplies Services) could help broaden its reach into infant and clinical nutrition — markets projected to grow.

  • Quality certifications (e.g., European suitability for its calcium products) could provide regulatory edge in international markets.

  • The broader Indian pharma industry is projected to grow, driven by domestic demand, innovation, and increasing global relevance.


Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Sudeep Pharma IPO.

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
Aarvee Engineering Consultants Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aastha Spintex Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Absolute Project India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AceVector Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Adroit Industries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanta Enterprises Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advit Jewels Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aggcon Equipments International Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alcobrew Distilleries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allied Engineering Works Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alpine Texworld Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Annu Projects Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AOne Steels India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
APPL Containers Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ardee Engineering Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
EMIAC TECHNOLOGIES LIMITED IPO
Closing Today
Bidding Period
27th Mar 2026 - 4th Apr 2026
Price Range
₹93.0 - 98.0
IPO Size
₹32,00,00,000
SAFETY CONTROLS AND DEVICES LIMITED IPO
Closing Today
Bidding Period
6th Apr 2026 - 4th Apr 2026
Price Range
₹75.0 - 80.0
IPO Size
₹48,00,00,000
VIVID ELECTROMECH LIMITED IPO
Bidding Period
25th Mar 2026 - 3rd Mar 2026
Price Range
₹528.0 - 555.0
IPO Size
₹1,31,00,00,000
SAI PARENTERAL'S LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹372.0 - 392.0
IPO Size
₹4,09,00,00,000
AMIR CHAND JAGDISH KUMAR EXPORTS LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹201.0 - 212.0
IPO Size
₹4,40,00,00,000
HIGHNESS MICROELECTRONICS LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹114.0 - 120.0
IPO Size
₹22,00,00,000
POWERICA LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹375.0 - 395.0
IPO Size
₹11,00,00,00,000
TIPCO ENGINEERING INDIA LIMITED IPO
Bidding Period
23rd Mar 2026 - 3rd Mar 2026
Price Range
₹84.0 - 89.0
IPO Size
₹61,00,00,000
SPECIALITY MEDICINES LIMITED IPO
Bidding Period
20th Mar 2026 - 3rd Mar 2026
Price Range
₹117.0 - 124.0
IPO Size
₹29,00,00,000
CENTRAL MINE PLANNING AND DESIGN INSTITUTE LIMITED IPO
Bidding Period
20th Mar 2026 - 3rd Mar 2026
Price Range
₹163.0 - 172.0
IPO Size
₹18,42,00,00,000
NOVUS LOYALTY LIMITED IPO
Bidding Period
17th Mar 2026 - 3rd Mar 2026
Price Range
₹139.0 - 146.0
IPO Size
₹60,00,00,000
GSP CROP SCIENCE LIMITED IPO
Bidding Period
16th Mar 2026 - 3rd Mar 2026
Price Range
₹304.0 - 320.0
IPO Size
₹4,00,00,00,000
INNOVISION LIMITED IPO
Bidding Period
10th Mar 2026 - 3rd Mar 2026
Price Range
₹494.0 - 519.0
IPO Size
₹3,06,00,00,000
RAAJMARG INFRA INVESTMENT TRUST IPO
Bidding Period
11th Mar 2026 - 3rd Mar 2026
Price Range
₹99.0 - 100.0
IPO Size
₹60,00,00,00,000
APSIS AEROCOM LIMITED IPO
Bidding Period
11th Mar 2026 - 3rd Mar 2026
Price Range
₹104.0 - 110.0
IPO Size
₹36,00,00,000
RAJPUTANA STAINLESS LIMITED IPO
Bidding Period
9th Mar 2026 - 3rd Mar 2026
Price Range
₹116.0 - 122.0
IPO Size
₹2,55,00,00,000
SRINIBAS PRADHAN CONSTRUCTIONS LIMITED IPO
Bidding Period
6th Mar 2026 - 3rd Mar 2026
Price Range
₹91.0 - 98.0
IPO Size
₹20,00,00,000
ELFIN AGRO INDIA LIMITED IPO
Bidding Period
5th Mar 2026 - 3rd Mar 2026
Price Range
₹47.0 - 47.0
IPO Size
₹25,00,00,000
SEDEMAC MECHATRONICS LIMITED IPO
Bidding Period
4th Mar 2026 - 3rd Mar 2026
Price Range
₹1287.0 - 1352.0
IPO Size
₹10,87,00,00,000
ACETECH ECOMMERCE LIMITED IPO
Bidding Period
27th Feb 2026 - 3rd Mar 2026
Price Range
₹106.0 - 112.0
IPO Size
₹49,00,00,000
  • All
  • MainBoard
  • SME
GSP CROP SCIENCE LIMITED IPO
Issue Prize
320.00
Listing Day Close
356.10(11.25%)
INNOVISION LIMITED IPO
Issue Prize
519.00
Listing Day Close
372.80(-28.13%)
RAAJMARG INFRA INVESTMENT TRUST IPO
Issue Prize
100.00
Listing Day Close
106.83(7.00%)
APSIS AEROCOM LIMITED IPO
Issue Prize
110.00
Listing Day Close
160.65(46.36%)
RAJPUTANA STAINLESS LIMITED IPO
Issue Prize
122.00
Listing Day Close
112.90(-7.38%)
SRINIBAS PRADHAN CONSTRUCTIONS LIMITED IPO
Issue Prize
98.00
Listing Day Close
104.40(6.12%)
ELFIN AGRO INDIA LIMITED IPO
Issue Prize
47.00
Listing Day Close
47.60(2.13%)
SEDEMAC MECHATRONICS LIMITED IPO
Issue Prize
1352.00
Listing Day Close
1452.10(7.40%)
ACETECH ECOMMERCE LIMITED IPO
Issue Prize
112.00
Listing Day Close
117.60(5.36%)
STRIDERS IMPEX LIMITED IPO
Issue Prize
72.00
Listing Day Close
66.50(-6.94%)
OMNITECH ENGINEERING LIMITED IPO
Issue Prize
227.00
Listing Day Close
205.15(-9.69%)
YAAP DIGITAL LIMITED IPO
Issue Prize
145.00
Listing Day Close
133.35(-8.28%)
PNGS REVA DIAMOND JEWELLERY LIMITED IPO
Issue Prize
386.00
Listing Day Close
413.95(7.25%)
SHREE RAM TWISTEX LIMITED IPO
Issue Prize
104.00
Listing Day Close
73.45(-29.81%)
CLEAN MAX ENVIRO ENERGY SOLUTIONS LIMITED IPO
Issue Prize
1053.00
Listing Day Close
867.90(-17.57%)
MOBILISE APP LAB LIMITED IPO
Issue Prize
80.00
Listing Day Close
67.30(-16.25%)
KIAASA RETAIL LIMITED IPO
Issue Prize
127.00
Listing Day Close
116.85(-7.87%)
ACCORD TRANSFORMER AND SWITCHGEAR LIMITED IPO
Issue Prize
46.00
Listing Day Close
52.50(15.22%)
GAUDIUM IVF AND WOMEN HEALTH LIMITED IPO
Issue Prize
79.00
Listing Day Close
80.48(1.27%)
MANILAM INDUSTRIES INDIA LIMITED IPO
Issue Prize
69.00
Listing Day Close
52.45(-24.64%)

Frequently Asked Questions

What is Sudeep Pharma Ltd IPO?

Answer Field

Sudeep Pharma Ltd IPO is a Mainboard IPO of 1,50,92,750 equity shares of a face value of ₹1 aggregating up to ₹895 Crores. The issue is priced at ₹563 to ₹593 per share. The minimum order quantity is 25 Shares. The IPO opens on November 21, 2025, and closes on November 25, 2025. MUFG Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

When Sudeep Pharma Ltd IPO will open?

Answer Field

The Sudeep Pharma Ltd IPO opens on November 21, 2025 and closes on November 25, 2025.

What is the lot size of Sudeep Pharma Ltd?

Answer Field

Sudeep Pharma Ltd lot size is 25 shares, and the minimum amount required is ₹14,825.

How to apply for Sudeep Pharma Ltd IPO?

Answer Field

You can apply in Sudeep Pharma Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Sudeep Pharma Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Sudeep Pharma Ltd IPO will be done on November 26, 2025, and the allotted shares will be credited to your demat account by November 27, 2025.

When is Sudeep Pharma Ltd IPO listing date?

Answer Field

The Sudeep Pharma Ltd listing date is November 28, 2025.

Who is the registrar of Sudeep Pharma Ltd IPO?

Answer Field

The registrar of Sudeep Pharma Ltd IPO is MUFG Intime India Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

ICICI Securities Limited,IIFL Capital Services Limited will be the book-running lead manager of this IPO.

What is the fresh issue of Sudeep Pharma Ltd IPO?

Answer Field

The fresh issue size is ₹95 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Sudeep Pharma Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 25 shares and ₹14,825 amount.

How can I approve the UPI mandate request for Sudeep Pharma Ltd IPO?

Answer Field

To apply for Sudeep Pharma Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Sudeep Pharma Ltd?

Answer Field

The price of each Sudeep Pharma Ltd share will be ranging in between ₹563 to ₹593 per share.

What is the cut-off time for the UPI mandate for Sudeep Pharma Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, November 25, 2025.

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|